Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)
Status:
Completed
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This is a phase 1/2a, randomized, double blind, single-center study comparing standard care
alone to standard care with Aggrastat in patients diagnosed with aneurysmal subarachnoid
hemorrhage.